Metropolitan Life Insurance Company (MetLife)’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ASTX Stock Details ASTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-82,313	Closed	-$698K	–	2812
2013 Q3	$698K	Buy	82,313 +1,866	+2%	+$11.8K	0.01%	1529
2013 Q2	$331K	Buy	+80,447	New	+$433K	﹤0.01%	1986

Metropolitan Life Insurance Company (MetLife)'s ASTX Position: Q4 2013 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 82,313 shares — an estimated $698K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $698K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

Metropolitan Life Insurance Company (MetLife) reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 82,313 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $698K.
Metropolitan Life Insurance Company (MetLife) first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
Metropolitan Life Insurance Company (MetLife)'s ASTEX PHARMACEUTICALS, INC COM position peaked at $698K in Q3 2013.
0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2013, filed 30 Jan 2014.